These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36263619)

  • 1. PD‑L1 mediates triple‑negative breast cancer evolution via the regulation of TAM/M2 polarization.
    Meng Z; Zhang R; Wu X; Zhang M; Jin T
    Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36263619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Salvianolic Acid A on Tumor-Associated Macrophage Polarization and Its Mechanisms in the Tumor Microenvironment of Triple-Negative Breast Cancer.
    Tang C; Jiang ST; Li CX; Jia XF; Yang WL
    Molecules; 2024 Mar; 29(7):. PubMed ID: 38611749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
    Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL
    Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen reverses epithelial-mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells.
    Wang Q; Cheng Y; Wang Y; Fan Y; Li C; Zhang Y; Wang Y; Dong Q; Ma Y; Teng YE; Qu X; Liu Y
    BMC Cancer; 2017 Jul; 17(1):492. PubMed ID: 28724364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling.
    Chen X; Yang M; Yin J; Li P; Zeng S; Zheng G; He Z; Liu H; Wang Q; Zhang F; Chen D
    Cell Commun Signal; 2022 Jun; 20(1):92. PubMed ID: 35715860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44v5 domain regulates crosstalk between TNBC cells and tumor-associated macrophages by enhancing the IL-4R/STAT3 axis.
    Dai Y; Ji Z; Liang H; Jiang M; Wang L; Bao X; Liu J; Liu M; Yang C
    Cancer Sci; 2024 Jul; 115(7):2235-2253. PubMed ID: 38700108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAMpepK Suppresses Metastasis through the Elimination of M2-Like Tumor-Associated Macrophages in Triple-Negative Breast Cancer.
    Lee C; Kim S; Jeong C; Cho I; Jo J; Han IH; Bae H
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-L1/p-STAT3 promotes the progression of NSCLC cells by regulating TAM polarization.
    Zhang R; Meng Z; Wu X; Zhang M; Piao Z; Jin T
    J Cell Mol Med; 2022 Dec; 26(23):5872-5886. PubMed ID: 36372977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR‑382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumor‑associated macrophages by targeting PGC‑1α.
    Zhou H; Gan M; Jin X; Dai M; Wang Y; Lei Y; Lin Z; Ming J
    Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 36069230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G6PD activation in TNBC cells induces macrophage recruitment and M2 polarization to promote tumor progression.
    Li Y; Han X; Lin Z; Wang C; Fu Z; Sun Q; Li C
    Cell Mol Life Sci; 2023 May; 80(6):165. PubMed ID: 37237244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anemoside A3 Inhibits Macrophage M2-Like Polarization to Prevent Triple-Negative Breast Cancer Metastasis.
    Liu P; Liu Y; Chen L; Fan Z; Luo Y; Cui Y
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC.
    Bao X; Shi R; Zhao T; Wang Y; Anastasov N; Rosemann M; Fang W
    Cancer Immunol Immunother; 2021 Jan; 70(1):189-202. PubMed ID: 32681241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects.
    Bai H; Padron AS; Deng Y; Liao YJ; Murray CJ; Ontiveros C; Kari SJ; Kancharla A; Kornepati AVR; Garcia M; Reyes RM; Gupta HB; Conejo-Garcia JR; Curiel T
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36759012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1/PD-L1 agents.
    Santoni M; Romagnoli E; Saladino T; Foghini L; Guarino S; Capponi M; Giannini M; Cognigni PD; Ferrara G; Battelli N
    Biochim Biophys Acta Rev Cancer; 2018 Jan; 1869(1):78-84. PubMed ID: 29126881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of PD‑L1 and PD‑L2 is associated with the tumor microenvironment of TILs and M2 TAMs and tumor differentiation in non‑small cell lung cancer.
    Sumitomo R; Huang CL; Fujita M; Cho H; Date H
    Oncol Rep; 2022 Apr; 47(4):. PubMed ID: 35169863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting FAPα-expressing tumor-associated mesenchymal stromal cells inhibits triple-negative breast cancer pulmonary metastasis.
    Li X; Chen M; Lu W; Tang J; Deng L; Wen Q; Huang M; Deng R; Ye G; Ye W; Zhang D
    Cancer Lett; 2021 Apr; 503():32-42. PubMed ID: 33482262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophages confer resistance to BET inhibition in triple-negative breast cancer by upregulating IKBKE.
    Qiao J; Chen Y; Mi Y; Jin H; Wang L; Huang T; Li H; Song Y; Cao J; Wu B; Wang Q; Zou Z
    Biochem Pharmacol; 2020 Oct; 180():114126. PubMed ID: 32603665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M2 polarization of tumor-associated macrophages is dependent on integrin β3 via peroxisome proliferator-activated receptor-γ up-regulation in breast cancer.
    Shu Y; Qin M; Song Y; Tang Q; Huang Y; Shen P; Lu Y
    Immunology; 2020 Aug; 160(4):345-356. PubMed ID: 32311768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All-Trans Retinoic Acid Prevents Osteosarcoma Metastasis by Inhibiting M2 Polarization of Tumor-Associated Macrophages.
    Zhou Q; Xian M; Xiang S; Xiang D; Shao X; Wang J; Cao J; Yang X; Yang B; Ying M; He Q
    Cancer Immunol Res; 2017 Jul; 5(7):547-559. PubMed ID: 28515123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.